全文获取类型
收费全文 | 172001篇 |
免费 | 33406篇 |
国内免费 | 2558篇 |
专业分类
耳鼻咽喉 | 5320篇 |
儿科学 | 5828篇 |
妇产科学 | 2790篇 |
基础医学 | 5641篇 |
口腔科学 | 2033篇 |
临床医学 | 28389篇 |
内科学 | 53081篇 |
皮肤病学 | 7834篇 |
神经病学 | 17402篇 |
特种医学 | 7043篇 |
外科学 | 44288篇 |
综合类 | 269篇 |
现状与发展 | 72篇 |
一般理论 | 5篇 |
预防医学 | 7897篇 |
眼科学 | 3752篇 |
药学 | 2275篇 |
中国医学 | 36篇 |
肿瘤学 | 14010篇 |
出版年
2024年 | 523篇 |
2023年 | 4907篇 |
2022年 | 1295篇 |
2021年 | 3732篇 |
2020年 | 6389篇 |
2019年 | 2709篇 |
2018年 | 7973篇 |
2017年 | 7784篇 |
2016年 | 8910篇 |
2015年 | 8973篇 |
2014年 | 16330篇 |
2013年 | 16713篇 |
2012年 | 7275篇 |
2011年 | 7261篇 |
2010年 | 11345篇 |
2009年 | 15123篇 |
2008年 | 7360篇 |
2007年 | 5673篇 |
2006年 | 7996篇 |
2005年 | 5267篇 |
2004年 | 4530篇 |
2003年 | 3234篇 |
2002年 | 3289篇 |
2001年 | 3945篇 |
2000年 | 3085篇 |
1999年 | 3325篇 |
1998年 | 3866篇 |
1997年 | 3651篇 |
1996年 | 3530篇 |
1995年 | 3358篇 |
1994年 | 2049篇 |
1993年 | 1668篇 |
1992年 | 1451篇 |
1991年 | 1477篇 |
1990年 | 1132篇 |
1989年 | 1232篇 |
1988年 | 1070篇 |
1987年 | 892篇 |
1986年 | 935篇 |
1985年 | 766篇 |
1984年 | 619篇 |
1983年 | 557篇 |
1982年 | 551篇 |
1981年 | 435篇 |
1980年 | 387篇 |
1979年 | 326篇 |
1978年 | 344篇 |
1977年 | 426篇 |
1975年 | 289篇 |
1972年 | 290篇 |
排序方式: 共有10000条查询结果,搜索用时 343 毫秒
131.
132.
The human microbiome comprises a diverse set of microorganisms, which play a mostly cooperative role in processes such as metabolism and host defense. Next-generation genomic sequencing of bacterial nucleic acids now can contribute a much broader understanding of the diverse organisms composing the microbiome. Emerging evidence has suggested several roles of the microbiome in pediatric hematology/oncology, including susceptibility to infectious diseases, immune response to neoplasia, and contributions to the tumor microenvironment as well as changes to the microbiome from chemotherapy and antibiotics with unclear consequences. In this review, the authors have examined the evidence of the role of the microbiome in pediatric hematology/oncology, discussed how the microbiome may be modulated, and suggested key questions in need of further exploration. 相似文献
133.
134.
Renuka V. Iyer MD Bhavana Konda MD MPH Christos Fountzilas MD Sarbajit Mukherjee MD MS Dwight Owen MD MS Kristopher Attwood PhD Chong Wang MA Orla Maguire PhD Hans Minderman PhD Sheryl-Ann Suffren BA Karen Hicks BS John Wilton PhD Robert Bies PhD Danielle Casucci BA Diane Reidy-Lagunes MD Manisha Shah MD 《Cancer》2020,126(16):3689-3697
135.
136.
Nicole L. Stout DPT Justin C. Brown PhD Anna L. Schwartz PhD FNP Timothy F. Marshall PhD Anna M. Campbell PhD MBE Larissa Nekhlyudov MD MPH David S. Zucker MD PhD Karen M. Basen-Engquist PhD MPH Grace Campbell PhD MSW RN Jeffrey Meyerhardt MD MPH Andrea L. Cheville MD MSSE Kelley R. Covington MS Jennifer A. Ligibel MD Jonas M. Sokolof DO Kathryn H. Schmitz PhD MPH Catherine M. Alfano PhD 《Cancer》2020,126(12):2750-2758
137.
Rosa Della Monica Mariella Cuomo Roberta Visconti Annabella di Mauro Michela Buonaiuto Davide Costabile Giulia De Riso Teodolinda Di Risi Elia Guadagno Roberto Tafuto Sabrina Lamia Alessandro Ottaiano Paolo Cappabianca Maria Laura Del Basso de Caro Fabiana Tatangelo Juergen Hench Stephan Frank Salvatore Tafuto Lorenzo Chiariotti 《Oncology research》2020,28(9):837-845
Unresectable neuroendocrine neoplasms (NENs) often poorly respond to standard therapeutic approaches.
Alkylating agents, in particular temozolomide, commonly used to treat high-grade brain tumors including glioblastomas, have recently been tested in advanced or metastatic NENs, where they showed promising response
rates. In glioblastomas, prediction of response to temozolomide is based on the assessment of the methylation
status of the MGMT gene, as its product, O6
-methylguanine-DNA methyltransferase, may counteract the damaging effects of the alkylating agent. However, in NENs, such a biomarker has not been validated yet. Thus, we
have investigated MGMT methylation in 42 NENs of different grades and from various sites of origin by two
different approaches: in contrast to methylation-specific PCR (MSP), which is commonly used in glioblastoma
management, amplicon bisulfite sequencing (ABS) is based on high-resolution, next-generation sequencing
and interrogates several additional CpG sites compared to those covered by MSP. Overall, we found MGMT
methylation in 74% (31/42) of the NENs investigated. A higher methylation degree was observed in welldifferentiated tumors and in tumors originating in the gastrointestinal tract. Comparing MSP and ABS results,
we demonstrate that the region analyzed by the MSP test is sufficiently informative of the MGMT methylation
status in NENs, suggesting that this predictive parameter could routinely be interrogated also in NENs. 相似文献
138.
M. Novi C. Vanni P. D. Parchi M. Di Paolo N. Piolanti M. Scaglione 《Musculoskeletal surgery》2020,104(1):43-48
Over the years, the number of total hip replacements has been steadily increasing. Despite the improvement in surgical results, the number of claims for malpractice is higher. The primary endpoint of this work is to provide an analysis of litigation after hip replacement, to outline what are the instigating causes and costs. The secondary endpoint is to propose a possible preventive strategy for an improved care and a reduction in legal proceedings. The data of this study were collected from medical and legal files and from professional liability insurance of our institution from January 2005 to December 2016. Out of a total of 4770 THA, 40 claims were received. Peripheral nerve injuries represent the first cause of litigation (37%), followed by infectious complications, leg length discrepancy, metallosis, dislocations of the implant and a case of deep vein thrombosis. From the analysis of the past trial judgment, complications such as nerve lesions and infections are almost always recognized, as a medical error, with a high percentage of claims settled. This study shows the necessity of preventive strategies to reduce the higher number of claims for malpractice in total hip arthroplasty. Some complications such as nerve injuries and infection are frequently considered directly dependent on physician’s errors. Litigations can be reduced providing evidence of a diligent execution of the surgical procedure and of a proper postoperative management: the correct compilation of a specific informed consent and adequate doctor–patient communication. 相似文献
139.
140.
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations. 相似文献